Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check2 days agoChange DetectedA new revision entry, v3.6.4, was added to the study record history. The previous revision, v3.6.3, was deleted.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe version history shows a new revision identifier (v3.6.3) replacing the previous (v3.6.2). This indicates a backend or UI update to the page without modifying the study data.SummaryDifference0.1%

- Check30 days agoChange DetectedA new revision entry Revision: v3.6.2 was added to the study record history and the previous Revision: v3.6.0 entry was removed, updating the page's version metadata to reflect the latest revision.SummaryDifference0.1%

- Check44 days agoChange DetectedVersion history now records a Last verified timestamp and a Last known status was note, and the revision label has been updated to v3.6.0. This reflects a metadata-level update to the study record's history.SummaryDifference3%

- Check51 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history, replacing the previous revision (v3.5.4). This indicates an updated version of the study record.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision v3.5.3 was removed, indicating the page has been updated to the latest version.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.